Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 42Unknown 10Terminated 9Recruiting 9Active not recruiting 3Withdrawn 2Not yet recruiting 2Suspended 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Myeloid 2Lymphoid 1

Conditions

Primary Myelofibrosis 1Polycythemia Vera 1Lymphoma, Follicular 1Bone Marrow Neoplasms 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Hydroxyurea × Clear all
NCT04217356 2026-01-26

ALLO-BAT

University Health Network, Toronto

Active not recruiting
90 enrolled
Myeloid

Bone Marrow Neoplasms, Primary Myelofibrosis

NCT05020652 2025-12-17

A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2 Active not recruiting
107 enrolled
Lymphoid

Lymphoma, Follicular

NCT05548062 2025-09-03

Prospero

Novartis

Active not recruiting
242 enrolled
Myeloid

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡